Central Admixture Pharmacy Services, Inc. recalls glycopyrrolate 1 mg/5 mL (0.2 mg/mL), For Anesthesia Use, Syringe, RX ONLY, CAPS, Inc., 2200 South 43rd Avenue, Phoenix,
Recalled August 9, 2023 · FDA recall D-0952-2023 · Central Admixture Pharmacy Services
Hazard
Lack of assurance of sterility. Validation data for decontamination cycles is lacking. · FDA Class II
Units
770 Syringes
Sold at
Nationwide in the USA
Description
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Product
glycopyrrolate 1 mg/5 mL (0.2 mg/mL), For Anesthesia Use, Syringe, RX ONLY, CAPS, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6084-1
Manufacturer(s)
Central Admixture Pharmacy Services, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →